Valuation: STERIS plc

Capitalization 20.35B 17.27B 15.79B 14.93B 27.82B 1,922B 28.09B 187B 73.08B 922B 76.32B 74.72B 3,187B P/E ratio 2026 *
25.8x
P/E ratio 2027 * 22.7x
Enterprise value 21.43B 18.19B 16.63B 15.72B 29.31B 2,024B 29.58B 197B 76.98B 972B 80.39B 78.7B 3,356B EV / Sales 2026 *
3.61x
EV / Sales 2027 * 3.29x
Free-Float
98.99%
Yield 2026 *
1.17%
Yield 2027 * 1.27%
1 day-2.92%
1 week-3.24%
Current month-4.35%
1 month-7.81%
3 months-17.73%
6 months-21.35%
Current year-18.17%
1 week 195.14
Extreme 195.14
217.37
1 month 195.14
Extreme 195.14
227.87
Current year 195.14
Extreme 195.14
269.44
1 year 195.14
Extreme 195.14
269.44
3 years 187.06
Extreme 187.065
269.44
5 years 159.21
Extreme 159.21
269.44
10 years 63.26
Extreme 63.26
269.44
Manager TitleAgeSince
Chief Executive Officer 53 28/07/2021
Director of Finance/CFO 59 17/08/2025
Compliance Officer - 31/07/2019
Director TitleAgeSince
Director/Board Member 76 31/03/2008
Director/Board Member 73 28/02/2005
Director/Board Member 54 30/04/2018
Change 5d. change 1-year change 3-years change Capi.($)
-2.92%-3.24%-8.15%+9.77% 20.35B
-3.09%-5.75%-37.07%-23.97% 147B
-2.32%-4.81%-8.93%-15.57% 97.77B
-0.15%-1.29%+54.24%+82.34% 58.67B
+2.12%-14.12%-8.00%+55.21% 50.8B
-2.50%+0.08%-11.03%-40.58% 42.55B
-5.59%-11.69% - - 33.42B
-0.49%-1.21%-28.98%-49.57% 23.39B
+1.21%+8.39%+51.77%-11.21% 23.03B
-0.79%+4.40%-19.45%-35.49% 18.74B
Average -1.45%-2.92%-1.73%-3.23% 51.56B
Weighted average by Cap. -1.81%-4.49%-8.35%-2.11%

Financials

2026 *2027 *
Net sales 5.94B 5.04B 4.61B 4.36B 8.12B 561B 8.2B 54.68B 21.34B 269B 22.29B 21.82B 930B 6.31B 5.35B 4.9B 4.63B 8.63B 596B 8.71B 58.05B 22.66B 286B 23.66B 23.16B 988B
Net income 793M 673M 616M 582M 1.08B 74.91B 1.09B 7.3B 2.85B 35.95B 2.97B 2.91B 124B 891M 756M 692M 654M 1.22B 84.2B 1.23B 8.2B 3.2B 40.41B 3.34B 3.27B 140B
Net Debt 1.08B 920M 841M 795M 1.48B 102B 1.5B 9.98B 3.89B 49.15B 4.07B 3.98B 170B 415M 352M 322M 305M 568M 39.21B 573M 3.82B 1.49B 18.82B 1.56B 1.52B 65B
Logo STERIS plc
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (71.1%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (19%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (9.9%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (47.4%), sales of consumables (30.9%) and sales of equipment (21.7%). Net sales are distributed geographically as follows Ireland (2%), the United States (73.4%) and other (24.6%).
Employees
17,787
Date Price Change Volume
08/05/26 207.45 $ -2.92% 885,215
07/05/26 213.70 $ -0.35% 557,791
06/05/26 214.46 $ +0.70% 617,178
05/05/26 212.97 $ +0.34% 566,825
04/05/26 212.25 $ -1.00% 545,733
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
207.45USD
Average target price
279.29USD
Spread / Average Target
+34.63%

Quarterly revenue - Rate of surprise